Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Clostridium difficile-specific antigenic peptide

A Clostridium difficile, specific technology, applied in the direction of bacterial antigen components, specific peptides, peptides, etc., can solve the problem of not being able to effectively eliminate Clostridium difficile

Active Publication Date: 2022-06-07
SHIJIAZHUANG HIPRO BIOTECH
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the current results of immunoassays on these surface-associated proteins show that these proteins still cannot effectively eliminate Clostridium difficile, and there is an urgent need to find more immunogenic target proteins for the preparation of Clostridium difficile vaccines, in order to prepare specific and effective vaccines. Clostridium difficile vaccine

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Clostridium difficile-specific antigenic peptide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0017] The technical solutions in the embodiments of the present invention will be described clearly and completely below. Obviously, the described embodiments are only a part of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts shall fall within the protection scope of the present invention.

[0018] 1. Cultivation of Clostridium difficile

[0019] The present invention selects 4 high toxigenic Clostridium difficile RT027 strains (RT027 / NAP1 / BI / ST01) and 3 low toxigenic Clostridium difficile RT017 strains for bacterial culture. Before using the strains, the cryopreserved strains were thawed at room temperature, inoculated into CDMN selective medium, and placed in an anaerobic tank at 37°C for 48-72 hours after the three-division line. A single colony was selected and transformed into CDMN culture medium for ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a specific antigenic peptide of Clostridium difficile, especially the specific antigenic peptide for highly toxigenic Clostridium difficile RT027, which comprises the amino acid sequence shown in SEQ ID No.1. Using the specific peptides and specific antibodies of the present invention, a new detection kit for high-yielding Clostridium difficile strains and a Clostridium difficile vaccine can be developed, which is of great significance for the detection and treatment of high-yielding Clostridium difficile strain infection.

Description

technical field [0001] The present invention relates to a specific antigen peptide of Clostridium difficile. Background technique [0002] Clostridium difficile ( Clostridioides difficile , CD) is a Gram-positive, spore-producing obligate anaerobe. CD is the main pathogen of antibiotic-associated diarrhea (AAD) in hospitals, which can cause mild to severe diarrhea, colitis, pseudomembranous colitis, toxic megacolon, etc., and even death in severe cases. In recent years, the emergence of highly toxin-producing Clostridium difficile (RT027 / NAP1 / BI / ST01) has led to a gradual increase in the morbidity and mortality of Clostridiodes difficile infection (CDI), causing tens of thousands of deaths worldwide each year. Costs run into the billions of dollars. [0003] In 2013, the CDC (Center for Disease Control and Prevention) listed Clostridium difficile infection at the top of the urgency level of "microorganisms that pose a public health threat". The pathogenicity of C. diffic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/33C12N15/31C07K16/12A61K39/08A61P31/04
CPCC07K14/33C07K16/1282A61K39/08A61P31/04Y02A50/30
Inventor 赵建宏李志荣张慧敏
Owner SHIJIAZHUANG HIPRO BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products